OssDsign nominated for AGS Innovation Award 2018

Uppsala 2018-03-20 OssDsign has been nominated for the German AGS Innovation Award 2018. The award is a yearly initiative from the German SPD's entrepreneurial branch AGS.

This years nominees were recognised for their excellence in innovation and sustainability and OssDsign is being nominated based on "their groundbreaking medical technology that enables bone regeneration in the skull and face".

The winner of the award will be presented and honored at a gala event in Berlin, later this year.

Since 2001, the SPD and the working group of the self-employed in the SPD (AGS), annually honors entrepreneurs who show excellence in innovation, entrepreneurial initiative as well as ecological and social commitment through their corporate management.

About OssDsign

OssDsign is a Swedish medtech company dedicated to creating regenerative implants for improved healing of bone defects. OssDsign provides neurosurgeons and reconstructive plastic surgeons around the world with an expanding range of innovative implant solutions for improved patient outcomes.

By combining clinical insight with proprietary material technology and patient-adapted design, OssDsign supplies an expanding range of tailored solutions for cranial repair and facial bone reconstruction. OssDsign’s technology is the result of collaboration between clinical researchers at the Karolinska University Hospital, Stockholm, and material science experts at the Ångström Laboratory at Uppsala University.